Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.7 |
mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |
mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.7 |